Berger K - Search Results

1

Tolerability and effectiveness of 4-factor prothrombin complex concentrate (4F-PCC) for warfarin and non-warfarin reversals.

Santibanez M, Lesch CA, Lin L, Berger K. Santibanez M, et al. Among authors: berger k. J Crit Care. 2018 Dec;48:183-190. doi: 10.1016/j.jcrc.2018.08.031. Epub 2018 Aug 26. J Crit Care. 2018. PMID: 30218958

2

Efficacy spectrum of antishivering medications: meta-analysis of randomized controlled trials.

Park SM, Mangat HS, Berger K, Rosengart AJ. Park SM, et al. Among authors: berger k. Crit Care Med. 2012 Nov;40(11):3070-82. doi: 10.1097/CCM.0b013e31825b931e. Crit Care Med. 2012. PMID: 22890247 Review.

3

Effect of early mobilization on sedation practices in the neurosciences intensive care unit: a preimplementation and postimplementation evaluation.

Witcher R, Stoerger L, Dzierba AL, Silverstein A, Rosengart A, Brodie D, Berger K. Witcher R, et al. Among authors: berger k. J Crit Care. 2015 Apr;30(2):344-7. doi: 10.1016/j.jcrc.2014.12.003. Epub 2014 Dec 11. J Crit Care. 2015. PMID: 25573283

4

Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.

Sin JH, Berger K, Lesch CA. Sin JH, et al. Among authors: berger k. J Crit Care. 2016 Dec;36:166-172. doi: 10.1016/j.jcrc.2016.06.024. Epub 2016 Jul 5. J Crit Care. 2016. PMID: 27546767

5

Effectiveness and Tolerability of Conivaptan and Tolvaptan for the Treatment of Hyponatremia in Neurocritically Ill Patients.

Der-Nigoghossian C, Lesch C, Berger K. Der-Nigoghossian C, et al. Among authors: berger k. Pharmacotherapy. 2017 May;37(5):528-534. doi: 10.1002/phar.1926. Epub 2017 Apr 17. Pharmacotherapy. 2017. PMID: 28295447

6

A Low-Dose 4F-PCC Protocol for DOAC-Associated Intracranial Hemorrhage.

Berger K, Santibañez M, Lin L, Lesch CA. Berger K, et al. J Intensive Care Med. 2020 Nov;35(11):1203-1208. doi: 10.1177/0885066619840992. Epub 2019 Apr 14. J Intensive Care Med. 2020. PMID: 30983472

7

Aminocaproic Acid for the Reversal of Alteplase: A Case Series.

Verkerk BS, Berger K, Lesch CA. Verkerk BS, et al. Among authors: berger k. J Pharm Pract. 2020 Dec;33(6):919-925. doi: 10.1177/0897190019840095. Epub 2019 May 7. J Pharm Pract. 2020. PMID: 31064251

8

Management of Hepatic Coagulopathy in Bleeding and Nonbleeding Patients: An Evidence-Based Review.

Lange NW, Salerno DM, Berger K, Cushing MM, Brown RS Jr. Lange NW, et al. Among authors: berger k. J Intensive Care Med. 2021 May;36(5):524-541. doi: 10.1177/0885066620903027. Epub 2020 Feb 21. J Intensive Care Med. 2021. PMID: 32079443 Review.

9

The Safety and Efficacy of Desmopressin in Patients With Intracranial Hemorrhage and a History of Alcohol Use.

Gunther M, Witenko CJ, Prust M, Salerno D, Berger K. Gunther M, et al. Among authors: berger k. J Intensive Care Med. 2022 Jun;37(6):825-832. doi: 10.1177/08850666211031494. Epub 2021 Jul 21. J Intensive Care Med. 2022. PMID: 34286612

10

Cryoprecipitate for Alteplase-Related Hemorrhagic Conversion of Acute Ischemic Stroke.

Verkerk BS, Lesch C, Cham S, Berger K. Verkerk BS, et al. Among authors: berger k. J Pharm Pract. 2023 Oct;36(5):1253-1259. doi: 10.1177/08971900221102116. Epub 2022 May 20. J Pharm Pract. 2023. PMID: 35593906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,237 results

Search Page

Filters